Stephen Sullivan holds a PhD, an MBA and a FRSM. As the Chief Operating Officer of iPSirius, his work in harnessing stem cell immunotherapy for aggressive cancers is revolutionary. Holding a PhD in Regenerative Medicine from the University of Edinburgh, Stephen's dedication to scientific exploration is deeply rooted in his educational pedigree. He's been a part of esteemed institutions such as Harvard, Cambridge, and the California Institute for Regenerative Medicine. Stephen's commitment to international quality, manufacturing standards, and rigorous top-down strategic thinking has empowered him to cultivate an extensive biomedical network. Whether it's R&D, GMP manufacture, regulatory affairs, or commercialization, Stephen has left indelible marks across the spectrum. He is known in the industry not just for his scientific acumen but also for his ability to foster trust, strengthen stakeholder relationships, and communicate intricate subjects to varied audiences with unparalleled clarity. However, what truly distinguishes Stephen is his ability to bridge the gap between intricate science and its real-world applications. His MBA from Trinity College Dublin underscores his proficiency in business strategy, ensuring that innovations don't just remain confined to labs but find their way to actual patient care.